Dendritic cells and tumor immunotherapy / 国际肿瘤学杂志
Journal of International Oncology
; (12): 755-758, 2012.
Article
in Zh
| WPRIM
| ID: wpr-419446
Responsible library:
WPRO
ABSTRACT
In vivo,dendritic cells(DCs)are the most powerful antigen-presenting cells (APCs).DCs based neoplasm immunotherapy has recently become the focus of research.DCs can be used not only as separate cell vaccine to mediate anti-tumor immunity,but can also be combined with cytokines,immune cells,and other methods in tumor immunotherapy. In animal models and clinical trials,DC-based immunotherapy as well as other tumor immunotherapy strategies have gained more significant progress.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of International Oncology
Year:
2012
Type:
Article